Literature DB >> 27890379

Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone - A novel class of compounds with potent activity against acute myeloid leukemia cells.

Brandon A Carter-Cooper1, Steven Fletcher2, Dana Ferraris3, Eun Yong Choi1, Dahlia Kronfli1, Smaraki Dash1, Phuc Truong3, Edward A Sausville1, Rena G Lapidus1, Ashkan Emadi4.   

Abstract

The synthesis, characterization and antileukemic activity of rationally designed amino dimeric naphthoquinone (BiQ) possessing aziridine as alkylating moiety is described. Bis-aziridinyl BiQ decreased proliferation of acute myeloid leukemia (AML) cell lines and primary cells from patients, and exhibited potent (nanomolar) inhibition of colony formation and overall cell survival in AML cells. Effective production of reactive oxygen species (ROS) and double stranded DNA breaks (DSB) induced by bis-aziridinyl BiQ is reported. Bis-dimethylamine BiQ, as the isostere of bis-aziridinyl BiQ but without the alkylating moiety did not show as potent anti-AML activity. Systemic administration of bis-aziridinyl BiQ was well tolerated in NSG mice. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemia; Aziridine; DNA damage; Naphthoquinone; Reactive oxygen species

Mesh:

Substances:

Year:  2016        PMID: 27890379      PMCID: PMC5654471          DOI: 10.1016/j.bmcl.2016.11.045

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  25 in total

1.  Survival for older patients with acute myeloid leukemia: a population-based study.

Authors:  Betul Oran; Daniel J Weisdorf
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

2.  Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity.

Authors:  Ashley E Ross; Ashkan Emadi; Luigi Marchionni; Paula J Hurley; Brian W Simons; Edward M Schaeffer; Milena Vuica-Ross
Journal:  BJU Int       Date:  2010-12-22       Impact factor: 5.588

3.  Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Hartmut Döhner; Peter J Campbell; Lars Bullinger; Verena I Gaidzik; Peter Paschka; Nicola D Roberts; Nicola E Potter; Michael Heuser; Felicitas Thol; Niccolo Bolli; Gunes Gundem; Peter Van Loo; Inigo Martincorena; Peter Ganly; Laura Mudie; Stuart McLaren; Sarah O'Meara; Keiran Raine; David R Jones; Jon W Teague; Adam P Butler; Mel F Greaves; Arnold Ganser; Konstanze Döhner; Richard F Schlenk
Journal:  N Engl J Med       Date:  2016-06-09       Impact factor: 91.245

Review 4.  Anti-cancer activities of 1,4-naphthoquinones: a QSAR study.

Authors:  Rajeshwar P Verma
Journal:  Anticancer Agents Med Chem       Date:  2006-09       Impact factor: 2.505

5.  The state of the union on treatment of acute myeloid leukemia.

Authors:  Ashkan Emadi; Judith E Karp
Journal:  Leuk Lymphoma       Date:  2014-03-25

6.  Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent.

Authors:  Michael Xiang; Haesook Kim; Vincent T Ho; Sarah R Walker; Michal Bar-Natan; Melodi Anahtar; Suhu Liu; Patricia A Toniolo; Yasmin Kroll; Nichole Jones; Zachary T Giaccone; Lisa N Heppler; Darwin Q Ye; Jason J Marineau; Daniel Shaw; James E Bradner; Traci Blonquist; Donna Neuberg; Claudio Hetz; Richard M Stone; Robert J Soiffer; David A Frank
Journal:  Blood       Date:  2016-08-16       Impact factor: 22.113

Review 7.  Cyclophosphamide and cancer: golden anniversary.

Authors:  Ashkan Emadi; Richard J Jones; Robert A Brodsky
Journal:  Nat Rev Clin Oncol       Date:  2009-09-29       Impact factor: 66.675

Review 8.  Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase.

Authors:  P Workman
Journal:  Oncol Res       Date:  1994       Impact factor: 5.574

9.  Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone.

Authors:  Gaurab Chakrabarti; Zachary R Moore; Xiuquan Luo; Mariya Ilcheva; Aktar Ali; Mahesh Padanad; Yunyun Zhou; Yang Xie; Sandeep Burma; Pier P Scaglioni; Lewis C Cantley; Ralph J DeBerardinis; Alec C Kimmelman; Costas A Lyssiotis; David A Boothman
Journal:  Cancer Metab       Date:  2015-10-12

10.  A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone.

Authors:  Lakshmi Swarna Mukhi Pidugu; J C Emmanuel Mbimba; Muqeet Ahmad; Edwin Pozharski; Edward A Sausville; Ashkan Emadi; Eric A Toth
Journal:  BMC Struct Biol       Date:  2016-01-28
View more
  1 in total

Review 1.  The diverse mechanisms and anticancer potential of naphthoquinones.

Authors:  Carolina Escardó Pereyra; Rafael Ferreira Dantas; Sabrina Baptista Ferreira; Luciano Pinho Gomes; Floriano Paes Silva-Jr
Journal:  Cancer Cell Int       Date:  2019-08-02       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.